J&J's Suponcic decamps for Kantar

Share this article:
Kantar Health said it hired Susan Suponcic, PhD, as SVP of global market access. In her new role, Suponcic will lead a global team assisting pharma clients in incorporating, substantiating and implementing market access initiatives, according to a company statement.
Suponcic has more than 13 years of market access experience in both industry and consulting. She joins Kantar Health from Johnson & Johnson (J&J), where she held strategic roles in both pricing and health economics, led teams that carried out global launches and helped shape the external environment to focus on the value of pharmaceutical innovation, Kantar said.
Prior to J&J, Suponcic worked on the consulting side, leading IMS Health's pharma pricing consulting practice.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"